Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia 1Bronchiolitis Obliterans Syndrome 1

Interventions

Blood Specimen Collection 15Imatinib Mesylate 10Flow Cytometry 10nilotinib 8Surveys and Questionnaires 8Polymerase Chain Reaction 8ponatinib 6Cytogenetic Analysis 6ruxolitinib 5bosutinib 5Psychiatric Rehabilitation 5Dasatinib 5Therapeutics 4Interviews as Topic 4Biopsy 4asciminib 3Observation 3Microarray Analysis 3In Situ Hybridization, Fluorescence 3Immunoenzyme Techniques 3Amplified Fragment Length Polymorphism Analysis 3olverembatinib 2fludarabine 2Watchful Waiting 2Tyrosine Kinase Inhibitors 2Molecular Diagnostic Techniques 2Influenza Vaccines 2Immunologic Techniques 2Immunohistochemistry 2Hydroxyurea 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Vision, Ocular × Myeloid × Clear all
NCT02085798 2020-01-27

Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)

Celgene

Completed
503 enrolled
MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡